High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists

The interleukin-6 family cytokine, oncostatin-M (OSM) has been associated with response to tumor necrosis factor-α antagonists (anti-TNFs) in small cohorts of patients with inflammatory bowel disease (IBD). We aimed to evaluate the association between plasma OSM concentrations and response to anti-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Angela, Ross, Cameron, Chande, Nilesh, Gregor, Jamie, Ponich, Terry, Khanna, Reena, Sey, Michael, Beaton, Melanie, Yan, Brian, Kim, Richard B., Wilson, Aze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786839/
https://www.ncbi.nlm.nih.gov/pubmed/35075155
http://dx.doi.org/10.1038/s41598-022-05208-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786839/
https://www.ncbi.nlm.nih.gov/pubmed/35075155
http://dx.doi.org/10.1038/s41598-022-05208-9

Ejemplares similares